Page last updated: 2024-08-24

capecitabine and Stevens-Johnson Syndrome

capecitabine has been researched along with Stevens-Johnson Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Karthikeyan, K; Madhu, CS; Sameera, KV; Shaji, S; Swetha, MAC1
Jadhav, P; Rogers, JE; Shroff, R1
Kilickap, S; Sendur, MA1

Other Studies

4 other study(ies) available for capecitabine and Stevens-Johnson Syndrome

ArticleYear
Capecitabine induced Steven-Johnson syndrome: A rare case report.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:1

    Topics: Aged; Antineoplastic Agents; Capecitabine; Fluorouracil; Humans; Male; Neoplasms; Stevens-Johnson Syndrome

2022
Capecitabine: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Prescrire international, 2014, Volume: 23, Issue:150

    Topics: Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Risk Assessment; Risk Factors; Stevens-Johnson Syndrome; Time Factors; United Kingdom

2014
A Case Report-Stevens-Johnson Syndrome as an Adverse Effect of Capecitabine.
    Journal of gastrointestinal cancer, 2018, Volume: 49, Issue:3

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Duodenal Neoplasms; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stevens-Johnson Syndrome

2018
Stevens-Johnson syndrome after treatment with capecitabine.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2008, Volume: 20, Issue:2

    Topics: Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Stevens-Johnson Syndrome

2008